Literature DB >> 21454106

Reconstructive surgery for deep vein reflux in the lower limbs: techniques, results and indications.

O Maleti1, M Perrin.   

Abstract

Deep venous reflux (DVR) is defined as a reflux affecting the deep venous system. DVR essentially arises from two aetiologies, primary deep valve incompetence (PDVI) and post-thrombotic syndrome (PTS), and it is correlated with severe chronic venous insufficiency. DVR correction aims at reducing the increased ambulatory venous pressure, which results from reflux in deep veins in orthodynamic conditions. The results of DVR surgery are not easy to assess, as it is mostly associated with surgery for insufficiency in the superficial venous system and/or perforators. In cases of primary insufficiency, valvuloplasty, the operation of choice, is credited at 5 years follow-up with a 70% success rate in terms of clinical outcome and improved haemodynamic performance. In PTS, a meta-analysis of transpositions and transplants at more than 5 years estimates successful clinical outcome and improved haemodynamic performance at 50%. The Maleti neovalve construction technique has achieved better results. Indications for DVR surgery are based on clinical, haemodynamic and imaging data. Aetiology is a decisive factor in the choice of the technique.
Copyright © 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21454106     DOI: 10.1016/j.ejvs.2011.02.013

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  2 in total

1.  Thinking Outside the Heart: Use of Engineered Cardiac Tissue for the Treatment of Chronic Deep Venous Insufficiency.

Authors:  Narine Sarvazyan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-02-04       Impact factor: 2.457

2.  Surgical Technique for Deep Venous Reflux Suppression in Femoral Vein Duplication.

Authors:  P Zamboni; S Gianesini
Journal:  EJVES Short Rep       Date:  2016-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.